THE FUNDING
JOURNEY
LEARN FROM FUNDING EXPERTS
This event provides life science companies with
all you need to know about the funding journey
from early stage proof of concept grants to equity
and raising finance through IPO.
In addition to top professionals from funding
agencies, Business Angel Groups, Fund
Managers, VCs and IPO specialists, you will hear
from CEOs / Entrepreneurs who have successfully
secured grants / investment in the past and are
prepared to share their experience with you.
Whether you are a CEO/CFO/CTO or COO you
will meet a remarkable range of experts under
one roof to take you through the funding journey
from early stage proof of concept grant funding
to equity and IPO.
Companies that have successfully secured a
variety of grants / investment funding will be on
hand to share their experiences with you.
For more info and to book, visit
www.eventbrite.co.uk/e/life-science-the-
funding-journey-tickets-37271863146
A CASE STUDY
Medilink member Viamed is
developing a wearable, self-
adjustable, wireless probe to
monitor oxygen levels in children.
The device is embedded with
paediatric software algorithms
which can be used in both children
and adults.
The Small Business Research
Initiative (SBRI) for Healthcare is
delivered in partnership with the
Academic Health Science Network
(AHSN) - in this instance the Yorkshire
and Humber AHSN.
Steve Nixon, director at Viamed,
said: “We are delighted with the SBRI
Healthcare award and the opportunity
to make a real difference by delivering
solutions that should improve the
quality of children’s lives.”
Paediatric long term conditions
such as severe asthma, cystic
fibrosis, congenital heart defects
and neonatal lung conditions lead to
severe morbidity or death if oxygen “As part of the project, Medilink’s
saturation levels are not monitored Innovation team helped implement
and appropriate action taken.
sophisticated best practice
Currently there are no optimised
methodologies to identify and
solutions to this problem.
prioritise needs that are translated
into design inputs.
Viamed’s innovation promises
improved outcomes to be delivered “This increased probability of
to patients. The Keighley-based
commercial success for the
company received the SBRI
device while significantly reducing
Healthcare award for its potential
commercialisation and technical risks
value to the patients and the health
during the development phase.”
service.
10
The project took off with a six
month feasibility phase and
has now moved on to a more
detailed product development.
The SBRI Phase one contracts
for feasibility testing are valued
at up to £100,000 and last for six
months. Phase two contracts
for prototype development are
worth up to £1 million over one
year.
At present, the project team
have completed a detailed
assessment of users’ needs.
This has already identified
some surprising findings that
have opened doors to new
innovations that were previously
not apparent.